These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1909231)

  • 1. Once-daily ceftriaxone outpatient therapy in adults with infections.
    Tice AD
    Chemotherapy; 1991; 37 Suppl 3():7-10. PubMed ID: 1909231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily ceftriaxone in the outpatient treatment of paediatric infections.
    Bradley JS
    Chemotherapy; 1991; 37 Suppl 3():3-6. PubMed ID: 1884651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings.
    Eron LJ; Goldenberg RI; Poretz DM
    Am J Surg; 1984 Oct; 148(4A):1-4. PubMed ID: 6091473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily intramuscular ceftriaxone in the outpatient treatment of severe community-acquired pneumonia in children.
    Leibovitz E; Tabachnik E; Fliedel O; Steinberg S; Miskin A; Askenazi A; Barak Y
    Clin Pediatr (Phila); 1990 Nov; 29(11):634-9. PubMed ID: 2265514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effective use of once-daily ceftriaxone: overview of a symposium.
    Periti P
    Chemotherapy; 1991; 37 Suppl 3():26-7. PubMed ID: 1909230
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.
    Pession A; Prete A; Paolucci G
    Chemotherapy; 1997; 43(5):358-66. PubMed ID: 9309370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient therapy of serious pediatric infections with ceftriaxone.
    Bradley JS; Ching DK; Phillips SE
    Pediatr Infect Dis J; 1988 Mar; 7(3):160-4. PubMed ID: 3357713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children.
    Frenkel LD
    Pediatrics; 1988 Sep; 82(3 Pt 2):486-91. PubMed ID: 3405685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient treatment of serious community-acquired pediatric infections using once daily intramuscular ceftriaxone.
    Dagan R; Phillip M; Watemberg NM; Kassis I
    Pediatr Infect Dis J; 1987 Dec; 6(12):1080-4. PubMed ID: 3324038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient treatment of serious infections in infants and children with ceftriaxone.
    Powell KR; Mawhorter SD
    J Pediatr; 1987 Jun; 110(6):898-901. PubMed ID: 3585606
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceftriaxone: a third-generation cephalosporin.
    Nahata MC; Barson WJ
    Drug Intell Clin Pharm; 1985 Dec; 19(12):900-6. PubMed ID: 3910386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient management of fever in children with sickle cell disease (SCD) in an African setting.
    Rahimy MC; Gangbo A; Ahouignan G; Anagonou S; Boco V; Alihonou E
    Am J Hematol; 1999 Sep; 62(1):1-6. PubMed ID: 10467269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M; Deamer RL; Prichard JG
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy.
    Duncan CJ; Evans TJ; Seaton RA
    J Antimicrob Chemother; 2010 Nov; 65(11):2483-4. PubMed ID: 20810422
    [No Abstract]   [Full Text] [Related]  

  • 15. Once daily ceftriaxone for central nervous system infections and other serious pediatric infections.
    Yogev R; Shulman ST; Chadwick EG; Davis AT; Glogowski W
    Pediatr Infect Dis; 1986; 5(3):298-303. PubMed ID: 3725639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci.
    Stamboulian D; Bonvehi P; Arevalo C; Bologna R; Cassetti I; Scilingo V; Efron E
    Rev Infect Dis; 1991; 13 Suppl 2():S160-3. PubMed ID: 2017645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily antibiotic regimen in paediatric oncology.
    Bouffet E; Fuhrmann C; Frappaz D; Couillioud D; Artiges V; Charra C; Bouhour D; Brunat Mentigny M
    Arch Dis Child; 1994 Jun; 70(6):484-7. PubMed ID: 8048816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Otolaryngology and infectious disease team approach for outpatient management of serious pediatric infections requiring parenteral antibiotic therapy.
    Einhorn M; Fliss DM; Leiberman A; Dagan R
    Int J Pediatr Otorhinolaryngol; 1992 Nov; 24(3):245-51. PubMed ID: 1399313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.